Literature DB >> 9635702

Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing.

A Eisbruch1, L H Marsh, M K Martel, J A Ship, R Ten Haken, A T Pu, B A Fraass, A S Lichter.   

Abstract

PURPOSE: Conformal treatment using static multisegmental intensity modulation was developed for patients requiring comprehensive irradiation for head and neck cancer. The major aim is sparing major salivary gland function while adequately treating the targets. To assess the adequacy of the conformal plans regarding target coverage and dose homogeneity, they were compared with standard irradiation plans. METHODS AND MATERIALS: Fifteen patients with stage III/IV head and neck cancer requiring comprehensive, bilateral neck irradiation participated in this study. CT-based treatment plans included five to six nonopposed fields, each having two to four in-field segments. Fields and segments were devised using beam's eye views of the planning target volumes (PTVs), noninvolved organs, and isodose surfaces, to achieve homogeneous dose distribution that encompassed the targets and spared major salivary gland tissue. For comparison, standard three-field radiation plans were devised retrospectively for each patient, with the same CT-derived targets used for the clinical (conformal) plans. Saliva flow rates from each major salivary gland were measured before and periodically after treatment.
RESULTS: On average, the minimal dose to the primary PTVs in the conformal plans [95.2% of the prescribed dose, standard deviation (SD) 4%] was higher than in the standard plans (91%, SD 7%; p = 0.02), and target volumes receiving <95% or <90% of the prescribed dose were smaller in the conformal plans (p = 0.004 and 0.02, respectively). Similar advantages of the conformal plans compared to standard plans were found in ipsilateral jugular nodes PTV coverage. The reason for underdosing in the standard treatment plans was primarily failure of electron beams to fully encompass targets. No significant differences were found in contralateral jugular or posterior neck nodes coverage. The minimal dose to the retropharyngeal nodes was higher in the standard plans. However, all conformal plans achieved the planning goal of delivering 50 Gy to these nodes. In the conformal plans, the magnitude and volumes of high doses in noninvolved tissue were significantly reduced. The main reasons for hot spots in the standard plans (whose dose calculations included missing tissue compensators) were photon/electron match line inhomogeneities, which were avoided in the conformal plans. The mean doses to all the major salivary glands, notably the contralateral parotid (receiving on average 32% of the prescribed dose, SD 7%) were significantly lower in the conformal plans compared with standard radiation plans. The mean dose to the noninvolved oral cavity tended to be lower in the conformal plans (p = 0.07). One to 3 months after radiation, on average 60% (SD 49%) of the preradiation saliva flow rate was retained in the contralateral parotid glands and 10% (SD 16%) was retained in the submandibular/sublingual glands.
CONCLUSIONS: Planning and delivery of comprehensive irradiation for head and neck cancer using static, multisegmental intensity modulation are feasible. Target coverage has not been compromised and dose distributions in noninvolved tissue are favorable compared with standard radiation. Substantial major salivary gland function can be retained.

Entities:  

Mesh:

Year:  1998        PMID: 9635702     DOI: 10.1016/s0360-3016(98)00082-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  22 in total

Review 1.  Recent advances: Radiotherapy.

Authors:  R P Symonds
Journal:  BMJ       Date:  2001-11-10

2.  Ten years of progress in head and neck cancers.

Authors:  Shrujal Baxi; Matthew Fury; Ian Ganly; Shyam Rao; David G Pfister
Journal:  J Natl Compr Canc Netw       Date:  2012-07-01       Impact factor: 11.908

3.  The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy.

Authors:  Yun Li; Jeremy M G Taylor; Randall K Ten Haken; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-04       Impact factor: 7.038

4.  Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.

Authors:  Valentina Krstevska; Simonida Crvenkova
Journal:  Croat Med J       Date:  2006-02       Impact factor: 1.351

Review 5.  Clinical application of intensity-modulated radiotherapy for head and neck cancer.

Authors:  O Ballivy; R Galiana Santamaría; A Lozano Borbalas; F Guedea Edo
Journal:  Clin Transl Oncol       Date:  2008-07       Impact factor: 3.405

Review 6.  Current advances in radiotherapy of head and neck malignancies.

Authors:  G Roopashri; Muqeet Baig
Journal:  J Int Oral Health       Date:  2013-12-26

7.  Acupuncture-Like Transcutaneous Electrical Nerve Stimulation Versus Pilocarpine in Treating Radiation-Induced Xerostomia: Results of RTOG 0537 Phase 3 Study.

Authors:  Raimond K W Wong; Snehal Deshmukh; Gwen Wyatt; Stephen Sagar; Anurag K Singh; Khalil Sultanem; Phuc F Nguyen-Tân; Sue S Yom; Joseph Cardinale; Min Yao; Ian Hodson; Chance L Matthiesen; John Suh; Harish Thakrar; Stephanie L Pugh; Lawrence Berk
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-01       Impact factor: 7.038

Review 8.  Recent advances in radiotherapy.

Authors:  S A Bhide; C M Nutting
Journal:  BMC Med       Date:  2010-04-28       Impact factor: 8.775

9.  Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer.

Authors:  Avraham Eisbruch; Jonathan A Ship; Laura A Dawson; Hyungjin M Kim; Carol R Bradford; Jeffrey E Terrell; Douglas B Chepeha; Theodore N Teknos; Norman D Hogikyan; Yoshimi Anzai; Lon H Marsh; Randall K Ten Haken; Gregory T Wolf
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

10.  Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number.

Authors:  Francis P Worden; Bhavna Kumar; Julia S Lee; Gregory T Wolf; Kitrina G Cordell; Jeremy M G Taylor; Susan G Urba; Avraham Eisbruch; Theodoros N Teknos; Douglas B Chepeha; Mark E Prince; Christina I Tsien; Nisha J D'Silva; Kun Yang; David M Kurnit; Heidi L Mason; Tamara H Miller; Nancy E Wallace; Carol R Bradford; Thomas E Carey
Journal:  J Clin Oncol       Date:  2008-05-12       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.